Portfolio
Strategy
Team
News
Careers
Contact
Investor Login
Portfolio
Strategy
Team
News
Careers
Contact
Artiva Biotherapeutics Announces First Patient Dosed in Phase 1 Trial of AlloNK® Cell Therapy Candidate in Lupus Nephritis
Read Article
News
2024
2023
Archive
Search news articles
February 2, 2017
KINESTRAL TECHNOLOGIES RAISES $65 MILLION IN SERIES C FUNDING, PREPARES TO LAUNCH HALIO™, THE WORLD’S MOST ADVANCED SMART-TINTING GLASS
February 2, 2017
AUDENTES THERAPEUTICS ANNOUNCES FDA CLEARANCE OF INVESTIGATIONAL NEW DRUG APPLICATION FOR AT342 TO TREAT CRIGLER-NAJJAR SYNDROME
February 1, 2017
GENEPEEKS APPOINTS INDUSTRY LEADER MATT POSARD AS PRESIDENT AND CHIEF COMMERCIAL OFFICER
January 24, 2017
GENEPEEKS LAUNCHES PRECONCEPTION TEST FOR COMBINED RISK OF PASSING ON MORE THAN 1,000 SERIOUS GENETIC DISEASES
January 23, 2017
HOMOLOGY MEDICINES AND IDEAYA BIOSCIENCES FEATURED ON BIOSPACE.COM’S TOP 20 LIFE SCIENCE STARTUPS TO WATCH IN 2017
January 18, 2017
BIRD ROCK BIO RECEIVES APPROVAL TO START FIRST IN HUMAN CLINICAL TRIAL FOR NAMACIZUMAB, ENTERS INTO AGREEMENT WITH GE HEALTHCARE
January 17, 2017
PULMATRIX DRUG CANDIDATE RECEIVES “QUALIFIED INFECTIOUS DISEASE PRODUCT” (QIDP) DESIGNATION FROM THE FDA
January 9, 2017
AUDENTES THERAPEUTICS PROVIDES FULL YEAR 2017 STRATEGIC OUTLOOK AND FINANCIAL GUIDANCE
January 5, 2017
ARVINAS APPOINTS DR. JOHN HOUSTON AS PRESIDENT OF RESEARCH AND DEVELOPMENT AND CHIEF SCIENTIFIC OFFICER
January 5, 2017
APREA THERAPEUTICS ANNOUNCES PRESENTATION AT THE 35TH ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE IN SAN FRANCISCO
« Previous Page
1
…
6
7
8